[New advance of the molecular targeting agents in advanced non-small cell lung cancer]

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Cancer cells exhibit distinct molecular biological differences compared to normal cells.
• Targeting these molecular differences offers a strategy to selectively inhibit tumor growth.
• Molecule-targeting agents represent a class of therapeutics designed for precision cancer treatment.

Purpose of the Study:

• To introduce and review emerging molecule-targeting agents for cancer therapy.
• To provide an overview of agents currently undergoing clinical trials.
• To highlight the potential of targeted therapies in oncology.

Main Methods:

• Literature review of ongoing clinical trials for molecule-targeting agents.
• Analysis of the mechanisms of action for selected agents.
• Summary of the current status of these agents in clinical development.

Main Results:

• Several promising molecule-targeting agents are advancing through clinical trials.
• These agents demonstrate the potential to selectively target and eliminate tumor cells.
• The development pipeline includes diverse therapeutic strategies targeting various cancer pathways.

Conclusions:

• Molecule-targeting agents are a rapidly evolving area in cancer treatment.
• Ongoing clinical trials are evaluating the efficacy and safety of novel targeted therapies.
• These agents hold significant promise for improving outcomes in cancer patients through precision medicine.